News for 'Glaxo'

The rise of the Indian pharma cos

The rise of the Indian pharma cos

Rediff.com4 Apr 2006

TCS, Bharti among 25 best employers

TCS, Bharti among 25 best employers

Rediff.com10 Dec 2004

Tata Consultancy Services along with Bharti Televentures and National Thermal Power Corp was on Friday adjudged among the best employers in India by leading global human resources management firm Hewitt Associates.

Indian pharma cos garner 80% market share

Indian pharma cos garner 80% market share

Rediff.com12 Mar 2007

Foreign multinational drug makers, barring GlaxoSmithKline Pharmaceuticals, continue to have a miniscule presence in the domestic market even after the product patent regime came into being.

40 Years Ago...and now: Earning respect for the ad craft

40 Years Ago...and now: Earning respect for the ad craft

Rediff.com11 Sep 2014

Mohammed Khan, co-founder of one of India's largest ad agencies, Rediffusion, talks about how the business has changed.

GSK may double headcount

GSK may double headcount

Rediff.com12 Apr 2005

GlaxoSmithKline Pharmaceuticals Limited is expanding its clinical trial data management, analyses and reporting activities in India where it plans to double the headcount depending on business needs.

MNCs plan big payouts

MNCs plan big payouts

Rediff.com23 Mar 2005

Nestle, ITC, HUL: The top three bidders for Horlicks

Nestle, ITC, HUL: The top three bidders for Horlicks

Rediff.com27 Jun 2018

Names such as Danone, Dabur, Mondelez and Abbott Healthcare have also figured on the list of suitors.

Return of the natives a tonic for pharma cos

Return of the natives a tonic for pharma cos

Rediff.com20 Feb 2007

Having moved into original research, they have attracted overseas professionals looking to come back, some nudged by MNCs' narrowing research.

Ranbaxy, Cipla keen to make bird flu drug

Ranbaxy, Cipla keen to make bird flu drug

Rediff.com26 Oct 2005

The government on Wednesday said Indian drug makers Ranbaxy and Cipla have approached it for assistance in manufacturing Tamiflu to fight bird flu

These stocks actually gained

These stocks actually gained

Rediff.com18 May 2006

Adani Exports and GlaxoSmithKline Consumer were the only two A-group stocks that ended in the positive territory.

Drug MNCs want payoff for blockbusters

Drug MNCs want payoff for blockbusters

Rediff.com31 Jan 2005

Most foreign drug makers have 100% subsidiaries in India, apart from their listed arms.

ATP players to get approved supplements

ATP players to get approved supplements

Rediff.com16 Nov 2004

The organisers of the men's tour will unveil a partnership deal with a pharmaceutical giant on Tuesday to provide approved nutritional supplements to players next season.\n

SAS plans huge R&D hub in Pune

SAS plans huge R&D hub in Pune

Rediff.com2 Dec 2005

SAS, global leaders in business intelligence solutions, on Friday announced setting up of its largest research and development centre in Pune, as it expects the Indian market to grow by 27 per cent and generate $87.4 billion worth business by 2009.

Ranbaxy gets FDA nod for Amoxicillin

Ranbaxy gets FDA nod for Amoxicillin

Rediff.com8 Dec 2003

Ranbaxy Laboratories on Monday said it has received final approval from the United States Food and Drugs Administration to manufacture and market Amoxicillin and Clavulnate Potassium tablets, a generic version of GlaxoSmithkline's Augmentin.

The world's largest wine company is.?

The world's largest wine company is.?

Rediff.com13 Jul 2004

Take the Rediff Business Quiz and see if you know which are the world's top steel, pharma, wine comapnies.

What lies ahead for Brand Horlicks?

What lies ahead for Brand Horlicks?

Rediff.com11 Dec 2018

One of the oldest living brands in the country, Horlicks has been innovative in its approach, which helped it survive intense competition

Big blow: India revokes GSK cancer drug patent

Big blow: India revokes GSK cancer drug patent

Rediff.com2 Aug 2013

India's Supreme Court in April rejected a patent for Novartis AG's cancer drug Glivec, saying it was an amended version of a known molecule called imatinib, setting the precedent for more such cases in the country.

MNC pharma: The opportunity

MNC pharma: The opportunity

Rediff.com14 Sep 2004

Investors must carefully watch the developments on the MNC pipeline.

10 large caps for good returns in 2021

10 large caps for good returns in 2021

Rediff.com15 Jan 2021

Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.

Now sugar-free Horlicks

Now sugar-free Horlicks

Rediff.com8 Sep 2005

GlaxoSmithKline Consumer Healthcare on Thursday launched a new, sugar-free, low calorie avtar of its flagship brand Horlicks for health conscious adults.

Which is India's largest pharma company?

Which is India's largest pharma company?

Rediff.com25 Sep 2003

Take the Rediff Biz Quiz and find out how much you know about various Indian pharmaceutical companies.

Which Bollywood actor was once a Complan boy?

Which Bollywood actor was once a Complan boy?

Rediff.com12 Sep 2003

Take the Rediff Biz Quiz and find out how much you know about Indian malted beverages.

GSK relaunches Horlicks

GSK relaunches Horlicks

Rediff.com2 Jul 2003

Ranbaxy awaits US nod for generic drug

Ranbaxy awaits US nod for generic drug

Rediff.com13 Mar 2003

Ranbaxy Laboratories Ltd, India's top drugmaker by sales, said it expected to get US approvals for a paediatric dosage of its generic version of Augmentin, GlaxoSmithKline's blockbuster antibiotic, within a month.\n\n\n\n

Rajendra is Ranbaxy research head

Rajendra is Ranbaxy research head

Rediff.com5 Jul 2004

Pharma power

Pharma power

Rediff.com26 Jun 2004

Scan NYSE quotes now

Scan NYSE quotes now

Rediff.com11 Jan 2003

Micromax launches a new phone for just Rs 699!

Micromax launches a new phone for just Rs 699!

Rediff.com6 Feb 2015

Joy X-1800 has a 1.76 inch screen, 750 mAh battery, 0.08MP camera.

Ranbaxy Q1 net at Rs 280 cr

Ranbaxy Q1 net at Rs 280 cr

Rediff.com29 Apr 2003

India's top drug maker Ranbaxy Laboratories said on Tuesday its first-quarter net profit nearly tripled on booming exports of generic drugs to the United States.

Ranbaxy net falls 4.6%

Ranbaxy net falls 4.6%

Rediff.com31 Jul 2004

HUL Q3 net profit grows 9% to Rs 1,444 crore on volume growth

HUL Q3 net profit grows 9% to Rs 1,444 crore on volume growth

Rediff.com17 Jan 2019

Sales during the quarter under review stood at Rs 9,357 crore, up 12.42 per cent, as against Rs 8,323 crore in the corresponding period of the last fiscal

Which company owns the brand Burnol?

Which company owns the brand Burnol?

Rediff.com5 Jan 2004

Take the Rediff Biz Quiz and find out how much you know about brands in India.